UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018283 |
|---|---|
| Receipt number | R000021163 |
| Scientific Title | HLA-mismatched allogeneic hematopoietic stem cell transplantation for standard-risk advanced hematological disease using low-dose alemtuzumab |
| Date of disclosure of the study information | 2015/07/13 |
| Last modified on | 2023/07/20 02:00:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/13 05:04:36 | ||
| 2 | Update | 2015/07/13 23:02:14 | Key inclusion criteria |
|
| 3 | Update | 2019/01/14 15:50:23 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 4 | Update | 2021/07/17 18:35:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Address TEL Organization Organization Address Address Tel |
|
| 5 | Update | 2021/07/17 18:41:23 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2021/07/17 18:44:26 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2022/01/17 23:09:18 | Recruitment status Last follow-up date |
|
| 8 | Update | 2022/01/17 23:10:49 | Recruitment status |
|
| 9 | Update | 2022/07/19 23:42:53 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 10 | Update | 2023/07/20 02:00:39 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
